COVID-19 Resource Center
COVID-19 Resource Center
Source/Disclosures
Source: Press Release

Disclosures: Salomon is CEO and co-founder of CLEW. Steiner is chief commercial officer of CLEW.
July 07, 2020
1 min read
Save

FDA authorizes platform that predicts COVID-19 complications

Source/Disclosures
Source: Press Release

Disclosures: Salomon is CEO and co-founder of CLEW. Steiner is chief commercial officer of CLEW.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The FDA issued an emergency use authorization for CLEWICU, an artificial intelligence-based platform that identifies several COVID-19 complications hours before they occur, the manufacturer said in a press release.

“CLEWICU is a subscription software service deployed on the cloud that provides each customer a unique setup that varies based on many factors like size, term and integration needs,” Mitch Steiner, chief commercial officer of CLEW, told Healio Primary Care.

CLEWICU can show up three types of “unique” medical data, such as electronic health record, radiology records and video data, simultaneously. Photo source: CLEW.
CLEWICU can show up three types of “unique” medical data, such as electronic health record, radiology records and video data, simultaneously. Photo source: CLEW.

Gal Salomon, co-founder and CEO of CLEW, added that the company’s artificial intelligence-based algorithms were trained on 100,000 patients.

Mitch Steiner 
Mitch Steiner
Gal Salomon 
Gal Salomon

“CLEWICU provides predictive screening information to assist with the early identification of patients who are likely to be diagnosed with the common COVID-19 complications of respiratory failure or hemodynamic instability,” he said in an interview. “Additionally, a remotely located clinician can use CLEWICU to safely support ICUs and provide support to address overloading and understaffing.”

According to the release, the product’s “streamlined at-a-glance web application” also allows almost real-time access to patient information and offers tools for worklist and unit and multi-unit views. Those tools allow physicians to simultaneously view up to three “unique” sets of medical information, Steiner explained.

“A [physician] can view information at the patient, multiple patients, multiple units and/or multiple hospital level,” he said. “There is also a high priority worklist view, which provides the physician all the data necessary to make decisions on the patients” that are part of the CLEWICU process, Steiner added.

Several hospitals in the United States are already using CLEWICU, according to the release.